Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed Aug 14, 2015 · 10-Q · 45 days after period end · 0001493152-15-003724
| Metric | Q2 2015 | Q2 2014 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Net Income | -$890.80K | -$427.57K | -$2.15K | -$1.20K |
| EPS Diluted | -$0.03 | -$0.04 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Jun 30, 2015 · filed Aug 14, 2015 · 45 d after period end
